UK-based Redx Pharma has closed a $36 million (€31 million) Series A financing round to support a Phase 2 trial of its Crohn’s disease drug candidate.
Tag Archive for: financing round
Bild von frimufilms auf FreepikHelsinki-based Aplagon has secured €7m in financing to advance its therapeutic APAC into Phase 2a clinical trials.
CatalymGerman cancer specialist Catalym GmbH has raised US$150m to finance proof-of-concept studies.
Danish Novo Holdings A/S and Abingworth co-led the largest European Series A financing round this year. Together with existing and new investors, they put £90m into cancer ADC specialist Myricx Bio Ltd.
Myoglobin producer Paleo NV has closed a € 12 m Series A round led by DSM Venturing and Planet A Ventures.